Unavailable
Unavailable
Save time and jump to the most important pieces.
F-3/A - Akso Health Group (0001702318) (Filer)
6-K - Akso Health Group (0001702318) (Filer)
6-K - Akso Health Group (0001702318) (Filer)
QINGDAO, China, Feb. 18, 2025 /PRNewswire/ -- Akso Health Group (NASDAQ:AHG) (hereinafter referred to as "Akso Health," "the Company," or "we") announced today its integration of DeepSeek's advanced artificial intelligence technology. This initiative aims to further enhance AI-powered medical consultation, optimize healthcare resource allocation, and provide users with more precise and efficient medical services. The utilization of DeepSeek not only represents a significant breakthrough in the field of AI-driven healthcare but also sets a new benchmark for the industry's intelligent transformation. As an innovative medical technology company, AHG leverages DeepSeek's multimodal large-scale
QINGDAO CHINA, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Akso Health Group (NASDAQ:AHG) ( "Akso Health," "the Company," or "we") today announced its plan to make an equity investment in Deyihui, an online clinic based in China. Akso Health plans to tap into the online clinic business initially in China and if the results are satisfactory, to expand this business to the other countries and regions. Given the rapid growth of virtual consultations in mainland China, management believes this is a significant untapped market where the Company may leverage its capital resources as well as first-move advantage. The planned equity investment in Deyuhui is expected to aid management in getting famili
BEIJING, Oct. 16, 2023 (GLOBE NEWSWIRE) -- Akso Health Group (NASDAQ:AHG) ("Akso Health" the "Company" or "we"), announced today that on October 11, 2023, it received a letter from the Nasdaq Listing Qualifications Department notifying the Company that it had regained compliance with the minimum bid price requirement. On October 26, 2022, the Company received a notification that it's American Depositary Shares ("ADS") failed to maintain a minimum bid price of $1.00 over the previous 30 consecutive business days, as required by Nasdaq Listing Rules of The Nasdaq Stock Market. The closing bid price of the Company's ADS was at $1.00 per share or greater from September 15, 2023 to October 10,